自动调节与手动调节无创通气治疗肥胖低通气综合征的有效性:一项随机临床试验
本研究为多中心、盲法、平行组、非劣效性及成本效益试验,纳入205例未接受过治疗的肥胖低通气综合征门诊患者,随机分配至自动调节无创通气组(容量目标压力支持联合自动呼气末正压,107例)或手动调节无创通气组(双水平气道正压自发/定时模式,89例)。主要终点为12个月时日间PaCO2的变化,非劣效界值设为-2 mmHg。结果显示,自动调节组PaCO2改善-9.2 mmHg(95%CI -9.7至-8.7),手动调节组改善-8.7 mmHg(95%CI -9.1至-8.3),组间平均校正差异为0.15 mmHg(低置信限-1.4),非劣效性P=0.01。成本效益分析显示自动调节组每例患者节省1528欧元(95%CI -2370至-6854)。其他次要结局无显著差异。结论认为,自动调节无创通气长期疗效不劣于手动调节且更具成本效益,作者认为鉴于其更低的复杂性和成本,临床实践中可能更倾向于选择自动调节无创通气。
要点
- 在205例肥胖低通气综合征门诊患者中,自动调节无创通气12个月时PaCO2改善-9.2 mmHg,手动调节组改善-8.7 mmHg,组间差异0.15 mmHg(低置信限-1.4),达到非劣效性(P=0.01)。
- 自动调节无创通气组每例患者节省1528欧元(95%CI -2370至-6854),成本效益优于手动调节组。
- 两组在症状、生活质量及医疗资源利用等其他次要结局上无显著差异。
- 作者认为,鉴于自动调节无创通气更低的复杂性和成本,临床实践中可能更倾向于选择该模式。
适用人群与场景
- 未接受过治疗的肥胖低通气综合征门诊患者(ambulatory patients with OHS)。
处置流程与药物剂量
- 自动调节无创通气:容量目标压力支持联合自动呼气末正压。
- 手动调节无创通气:双水平气道正压自发/定时模式(bilevel PAP ST),在多导睡眠监测下滴定。
研究设计与关键结果
- 研究类型:多中心、盲法、平行组、非劣效性及成本效益随机临床试验;样本量205例(自动调节组107例,手动调节组89例);人群为未治疗的门诊肥胖低通气综合征患者。
- 主要终点:12个月时日间PaCO2变化,自动调节组-9.2 mmHg(95%CI -9.7至-8.7),手动调节组-8.7 mmHg(95%CI -9.1至-8.3),组间平均校正差异0.15 mmHg(低置信限-1.4),非劣效性P=0.01。
- 成本效益:自动调节组每例患者节省1528欧元(95%CI -2370至-6854)。
- 次要终点:症状、生活质量及医疗资源利用等其他次要结局无显著差异。
证据类型、等级与局限
- 证据类型:随机对照试验(非劣效性及成本效益试验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,自动调节无创通气可能因其更低的复杂性和成本而在临床实践中更受青睐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Obesity hypoventilation syndrome (OHS) is treated with noninvasive ventilation (NIV) that is titrated during polysomnography. Auto-adjusted NIV could obviate the need for polysomnographic titration, thereby reducing costs and delays in care. However, non-inferiority long-term clinical trials comparing auto-adjusted NIV with manually-adjusted NIV are lacking.
OBJECTIVES: To determine the comparative effectiveness of automatic vs manual NIV modality in OHS.
METHODS: In this multicenter, blinded, parallel group, non-inferiority and cost-effectiveness trial, we randomly assigned treatment-naïve ambulatory patients with OHS to auto-adjusted NIV (volume-targeted pressure support with auto-expiratory positive airway pressure) or manually-adjusted NIV (bilevel Positive Airway Pressure Spontaneous Timed mode (PAP ST).
MEASUREMENTS: The primary outcome was change in daytime PaCO2 at 12 months, with the non-inferiority premise set at -2 mm Hg. Secondary outcomes included symptoms, quality of life, and healthcare resource utilization. Intention-to-treat and per-protocol analyses were performed.
MAIN RESULTS: 205 ambulatory patients with OHS were randomized, 107 to auto-adjusted NIV and 89 to manually-adjusted NIV. The mean [95% CI] improvement in PaCO2 was -9.2 [-9.7; -8.7] mm Hg in the auto-adjusted group and -8.7 [-9.1; -8.3] mm Hg in the manually-adjusted group, with mean adjusted difference of 0.15 mm Hg between groups ([low confidence limit -1.4]; non-inferiority P = .01). Cost-effectiveness was favorable to auto-adjusted group with a saving of 1528 € (95% CI, -2 370; -6 854) per patient. There were no significant differences in other secondary outcomes.
CONCLUSIONS: In ambulatory patients with OHS, auto-adjusted NIV had a non-inferior long-term effectiveness compared to manually-adjusted NIV while being more cost-effective. Auto-adjusted NIV may be preferred in clinical practice given its lower complexity and cost.
CLINICALTRIAL.GOV IDENTIFIER: NCT04327336.
参考来源
- Sánchez-Quiroga MÁ, Benítez I, Mokhlesi B, et al. Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial. Am J Respir Crit Care Med. 2026. PMID: 41738216. doi:10.1093/ajrccm/aamag018
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。